RMD Stock: Price, Earnings History and SEC Filings
ResMed Inc. (RMD) last traded at $229.94, down 9.05% on the latest session and up 4.0% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $2.91 against an analyst estimate of $2.67, a beat of 9.0%.
$229.94 -9.05%
1 month+4.00%
52-week high$277.67
52-week low$180.27
Volume3.45M
ExchangeNYSE
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
RMD earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 29, 2026 | $2.91 | $2.67 | +8.99% |
| Jun 2026 | Aug 6, 2026 | $2.95 | $2.90 | +1.72% |
| Mar 2026 | Apr 30, 2026 | $2.86 | $2.79 | +2.51% |
| Dec 2025 | Jan 29, 2026 | $2.81 | $2.69 | +4.46% |
RMD beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for RMD
SEC filing data is not available right now. You can search for RMD on SEC EDGAR.
RMD news
- RMD Q3 deep dive: product innovation and supply chain execution drive results amid evolving landscapeOct 31, 2026 · finance.yahoo.com
- ResMed (RMD) Looks Fully Valued After Another Earnings BeatOct 30, 2026 · finance.yahoo.com
- ResMed (RMD) Q1 2027 Earnings Call TranscriptOct 30, 2026 · fool.com
- ResMed (RMD) Reports Q1 Earnings: What Key Metrics Have to SayOct 30, 2026 · finance.yahoo.com
- ResMed Inc. Q1 2027 Earnings Call SummaryOct 30, 2026 · app.moby.co
- What ResMed (RMD) Said on Its Q1 Earnings CallOct 30, 2026 · marketbeat.com
- RMD Stock Up on Q1 Earnings and Revenue Beat, Gross Margin ClimbsOct 30, 2026 · finance.yahoo.com
- ResMed (NYSE:RMD) posts better-than-expected sales in Q3 CY2026Oct 29, 2026 · finance.yahoo.com
About ResMed Inc.
ResMed Inc. (RMD) is a US-listed public company on NYSE.